Niyamba Pharmaceutical Private Limited, a active private limited company, was established on 17 March 2016 in Satna, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MP2016PTC035563. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Rahul Singh (Director), Arti Soni (Director), Prema Singh Gaharwar (Director). Past directors included Prinsi Singh, Rahul Singh, Arti Soni. It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Mig-7 Navrang Park Birla Road,Kolgawan, Satna, Madhya Pradesh, 485001.
U24230MP2016PTC035563
035563
17 March 2016
₹1.00 M
₹0.10 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Niyamba Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rahul Singh | Director | 05 Mar 2022 | Current |
| Arti Soni | Director | 21 Apr 2017 | Current |
| Prema Singh Gaharwar | Director | 21 Apr 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 May 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 17 May 2017 | Past |
| Pramod Abcsdd | Additional Director | 17 May 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Niyamba Pharmaceutical Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.38% decrease. The company also saw a substantial fall in profitability, with a 80.64% decrease in profit. The company's net worth dipped by a decrease of 3.32%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Niyamba Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Dec 2019 | Others | ₹1.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Niyamba Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Niyamba Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Niyamba Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Niyamba Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Niyamba Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was completed.
The activity Rahul Singh was appointed as a Director was appointed as a Director on 05 Mar 2022 & has been associated with this company since 3 years 8 months . was completed.
A charge with Others amounted to Rs. 1.00 M with Charge ID 100312790 was registered on 12 Dec 2019. was recorded as a recent event.
Progress on Arti Soni was appointed as a Director was appointed as a Director on 21 Apr 2017 & has been associated with this company since 8 years 7 months . was documented.
Progress on Prema Singh Gaharwar was appointed as a Director was appointed as a Director on 21 Apr 2017 & has been associated with this company since 8 years 7 months . was documented.
The CIN of Niyamba Pharmaceutical Private Limited is U24230MP2016PTC035563.
Niyamba Pharmaceutical Private Limited is headquartered at Mig-7 Navrang Park Birla Road,Kolgawan, Satna, Madhya Pradesh, 485001.
Niyamba Pharmaceutical Private Limited was incorporated on 17 March 2016.
The current directors of Niyamba Pharmaceutical Private Limited are
The primary industry of Niyamba Pharmaceutical Private Limited is Manufacturing.
Niyamba Pharmaceutical Private Limited is unlisted.
The authorized capital of Niyamba Pharmaceutical Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Niyamba Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX